India Confronts ‘Profit-First’ Drug Pricing as Multinational Pharma Firms Accused of Exploiting Regulatory Gaps
A parliamentary investigation has exposed how multinational drug makers are reaping windfall mark-ups in India’s medicine market, with routine formulations showing price gaps of 600% to nearly 1,900%, signaling what…
















